GGrantIndex
← Leaderboards

Avner Schlessinger

University Of California, San Francisco

$6,740,500
Attributed
$9,975,081
Total exposure
9
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY201025
$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,975,081 · 9

By mechanism

R01$7,796,951 · 4
U01$1,005,513 · 1
T32$604,351 · 2
R21$464,750 · 1
F32$103,516 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Structure

Research focus

StructurePharmaceutical PreparationsSpecificityFamilyLigandsSmall MoleculeUptakeDesignProteinsCellsBiologicalBaseMolecularPlaySubstrate SpecificityDrug TargetingMalignant NeoplasmsMembranePharmacologySoluteMutationMediatingBindingBiomass

Grant awards (25)

Prenatal medication exposure in autism, birth complications and developmental disabilities$689,088
R01 · FY2025 · HD
Structural Studies and Drug Discovery to Interrogate the Function of Neuronal SLC4 Transporters$671,775
R01 · FY2025 · NS
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters$423,523
R01 · FY2025 · CA · contact PI
Integrated Training in Pharmacological Sciences$331,270
T32 · FY2025 · GM · contact PI
Prenatal medication exposure in autism, birth complications and developmental disabilities$682,197
R01 · FY2024 · HD
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters$402,346
R01 · FY2024 · CA · contact PI
Identifying New Astrocytic Kir4.1 Channel Modulators for Treating Huntington's Disease$211,250
R21 · FY2024 · NS
Prenatal medication exposure in autism, birth complications and developmental disabilities$694,097
R01 · FY2023 · HD
Multi-modal data integration to identify kinase substrates$507,000
U01 · FY2023 · CA
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters$437,751
R01 · FY2023 · CA · contact PI
Integrated Training in Pharmacological Sciences$273,081
T32 · FY2023 · GM · contact PI
Identifying New Astrocytic Kir4.1 Channel Modulators for Treating Huntington's Disease$253,500
R21 · FY2023 · NS
Prenatal medication exposure in autism, birth complications and developmental disabilities$680,747
R01 · FY2022 · HD
Multi-modal data integration to identify kinase substrates$498,513
U01 · FY2022 · CA
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters$376,866
R01 · FY2022 · GM · contact PI
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters$376,866
R01 · FY2021 · GM · contact PI
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters$376,866
R01 · FY2020 · GM · contact PI
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters$398,055
R01 · FY2019 · GM · contact PI
Substrate Specificity Determinants in Cancer-related Solute Carrier Transporters$314,747
R01 · FY2018 · GM · contact PI
Substrate Specificity Determinants in Cancer-related Solute Carrier Transporters$314,747
R01 · FY2017 · GM · contact PI
Substrate Specificity Determinants in Cancer-related Solute Carrier Transporters$314,747
R01 · FY2016 · GM · contact PI
Substrate Specificity Determinants in Cancer-related Solute Carrier Transporters$314,747
R01 · FY2015 · GM · contact PI
Substrate Specificity Determinants in Cancer-related Solute Carrier Transporters$327,786
R01 · FY2014 · GM · contact PI
Description of substrate specificity determinants in Solute Carrier Transporters$53,042
F32 · FY2011 · GM · contact PI
Description of substrate specificity determinants in Solute Carrier Transporters$50,474
F32 · FY2010 · GM · contact PI